The value of interferon therapy for COVID-19 in children

L. N. Mazankova; S. G. Gorbunov; E. R. Samitova

doi:10.22627/2072-8107-2021-20-1-34-38

Детские инфекции (Москва) (Apr 2021)

The value of interferon therapy for COVID-19 in children

L. N. Mazankova,
S. G. Gorbunov,
E. R. Samitova

Affiliations

L. N. Mazankova: Russian Medical Academy of Continuig Professional Education of the Ministry of Healthcare of the Russian Federation
S. G. Gorbunov: Russian Medical Academy of Continuig Professional Education of the Ministry of Healthcare of the Russian Federation
E. R. Samitova: Russian Medical Academy of Continuig Professional Education of the Ministry of Healthcare of the Russian Federation; Children's city clinical hospital of Z.A. Bashlyayeva of the Moscow Department of health

DOI: https://doi.org/10.22627/2072-8107-2021-20-1-34-38
Journal volume & issue: Vol. 20, no. 1
pp. 34 – 38

Abstract

Read online

The article presents a literature review, which provides data on the role of interferons in the immunopathogenesis of COVID-19 and the clinical efficacy of drugs based on recombinant interferon-alpha 2b in the treatment of children with new coronavirus infection. Shown the leading role ofinterferons as factors of the first line of defense against various viruses, including SARS-CoV-2. Numerous studies have proven the feasibility of including interferon preparations in COVID-19 therapyregimens in children, both as combinations with antiviral agents and as monotherapy.

Published in Детские инфекции (Москва)

ISSN: 2072-8107 (Print)
Publisher: LLC "Diagnostics and Vaccines"
Country of publisher: Russian Federation
LCC subjects: Medicine: Pediatrics
Website: http://detinf.elpub.ru/

About the journal

Abstract

Keywords